<DOC>
	<DOCNO>NCT00758628</DOCNO>
	<brief_summary>: The objective study determine bromfenac reduce diabetic macular edema ( DME ) adjunct argon laser therapy ( ALT ) . Leading cause Blindness working-aged population United States . 60 % patient Type-II DM , nearly Type-I DM progress Diabetic Retinopathy ( DR ) twenty year . Diabetic Macular Edema principal cause vision loss DR . Approximately 50 % patient DME experience loss &gt; =2 line best-corrected visualacuity ( VA ) 2 year follow-up . The pathogenesis DME multifactorial complex , intervention stratagem tend singular . Photocoagulation laser apply directly leak microaneurysms `` grid '' laser mainstay treatment since publication Early Treatment Diabetic Retinopathy Study ( ETDRS ) . This landmark clinical trial NIH sponsor , multicenter , control study demonstrate efficacy laser diabetic macular edema . It also demonstrate 20 % patient respond . Recent effort improve result focus pharmaceutical intervention inject vitreous cavity . The route administration lack substantiate efficacy problematic .</brief_summary>
	<brief_title>Randomized , Double Blind Trial Bromfenac BID ( 0.09 % ) Adjunct Argon Laser Therapy Treatment Diabetic Macular Edema .</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<criteria>Male female &gt; 18 year age schedule undergo argon laser therapy . Patients diabetic macular edema ( DME ) and/or proliferative diabetic retinopathy evidence ophthalmic examination diagnostics , either central macular peripheral involvement . Female subject childbearing potential must normal menstrual cycle negative urine pregnancy test result prior study entry . Women must either postmenopausal surgically sterile ( hysterectomy , bilateral tubal ligation , bilateral oopherectomy ) , woman childbearing potential must use effective method birth control . Acceptable method birth control include hormonal contraceptive ( i.e . pill , patch , ring , injection , implant ) , intrauterine device ( IUD ) , diaphragm spermicide condom spermicide . The incidence DME determine 2 method : Diagnosis clinical DME make mask investigator study base investigator 's medical opinion expertise Diagnosis DME mask clinical specialist review Optical Coherence Tomography ( OCT ) conclusion study . The diagnosis stratify 3 category : Definite DME : retinal swelling blur vision . Probable DME : Presence change retinal swelling blur vision note baseline follow . Possible DME : subtle moderate change retinal swelling blur vision note . Best Corrected Visual Acuity ( BCVA ) range 20/40 20/400 . Patients receive intravitreal/subtenon corticosteroid injection . Macular scarring/fibrosis , advanced cataract , advance glaucoma , retinal pigment epithelial detachment ( RPEDs ) . Other cause affect visual improvement . Allergy bromfenac NSAIDS . Sensitivity sulfite .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>